What Is a Peptide?

The word “peptide” comes up more and more in conversations about health, cosmetics, and biohacking. Anti-aging peptide serums, collagen peptides, therapeutic peptides — the term is everywhere. But what does it actually mean?

Peptides are fundamental molecules of life. Present in every cell of your body, they participate in biological processes as diverse as growth, tissue repair, cellular communication, and immune defense. Understanding what a peptide is means understanding one of the most basic mechanisms of biology.

This guide aims to give you a clear and comprehensive understanding of peptides: their chemical definition, their different types, their role in the body, and their current applications in medicine and cosmetics. Whether you are a healthcare professional, a skincare enthusiast, or simply curious, this guide is designed for you.

A peptide is a biological molecule consisting of a short chain of amino acids linked together by peptide bonds. The term comes from the Greek peptós (πεπτός), meaning “digested” — a historical reference to their discovery in the context of protein digestion.

To be precise, a peptide is defined as a chain containing between 2 and approximately 50 amino acids. This convention, though arbitrary, helps distinguish peptides from proteins, which are longer and more complex chains.

Amino acids are the basic units. There are 20 standard ones in the human genetic code (alanine, glycine, leucine, etc.), each with a distinct chemical structure. It is the order — the sequence — in which these amino acids are assembled that determines the identity and function of each peptide.

A few examples to illustrate:

• Dipeptide (2 amino acids): carnosine (beta-alanine + histidine), a natural antioxidant found in muscles
• Tripeptide (3 amino acids): glutathione (glutamate + cysteine + glycine), the body's “master antioxidant“
• Pentadecapeptide (15 amino acids): BPC-157, a research peptide studied for tissue repair

Each unique combination of amino acids produces a peptide with specific biological properties. It is this diversity that makes peptides such versatile and important molecules in biology.

The peptide bond is the chemical cement that joins amino acids together to form a peptide. Understanding this bond means understanding how peptides are built.

Each amino acid has two essential functional groups: an amine group (−NH₂) and a carboxyl group (−COOH). When two amino acids come together, the carboxyl group of the first reacts with the amine group of the second in a condensation reaction. This reaction releases a water molecule (H₂O) and forms a covalent C−N bond: this is the peptide bond.

The peptide bond has remarkable chemical properties:

• Partial rigidity: Unlike a simple covalent bond, the peptide bond has a partial double-bond character, which prevents free rotation around the C−N axis. This rigidity directly influences the three-dimensional shape of the peptide.
• Planarity: The six atoms involved in the peptide bond (Cα, C, O, N, H, Cα) lie in the same plane. This planarity is fundamental to understanding secondary structures (alpha helices, beta sheets).
• Stability: The peptide bond is thermodynamically stable under physiological conditions. Its cleavage (hydrolysis) requires the action of specific enzymes called proteases or peptidases.

The peptide chain thus formed has a directionality: an N-terminal end (with a free amine group) and a C-terminal end (with a free carboxyl group). By convention, a peptide's sequence is always written from the N-terminal to the C-terminal.

Beyond the primary structure (sequence), longer peptides can adopt secondary structures — alpha helices or beta sheets — stabilized by hydrogen bonds between the C=O and N−H groups of the main chain. These three-dimensional structures are crucial for the peptide's biological activity.

Peptides are classified according to several criteria: their size, origin, structure, or function. Here are the main categories:

Classification by size:

• Dipeptides (2 amino acids) — e.g.: carnosine, anserine
• Tripeptides (3 amino acids) — e.g.: glutathione, GHK-Cu
• Oligopeptides (2 to 20 amino acids) — e.g.: enkephalins, oxytocin
• Polypeptides (20 to 50 amino acids) — e.g.: insulin (51 AA, at the boundary), glucagon (29 AA)

Classification by biological function:

• Hormonal peptides: They act as chemical messengers in the endocrine system. Insulin, oxytocin, vasopressin, and glucagon are among the best known. These peptides regulate vital functions such as blood sugar, reproduction, and water balance.
• Neuropeptides: Active in the nervous system, they modulate synaptic transmission and behaviors. Endorphins (“happiness hormones”), substance P (pain), and neuropeptide Y (appetite) are major examples.
• Antimicrobial peptides (AMPs): Produced by the innate immune system, these peptides form a first line of defense against pathogens. Defensins and cathelicidins destroy bacterial membranes and regulate the immune response.
• Cell signaling peptides: They orchestrate communication between cells. Peptide growth factors (EGF, FGF, PDGF) control cell proliferation, differentiation, and migration.

Classification by structure:

• Linear peptides: A straight chain of amino acids without branching. This is the most common form.
• Cyclic peptides: The chain folds back on itself to form a ring, often stabilized by disulfide bridges. Cyclosporine (an immunosuppressant) is a famous example. Cyclic peptides are generally more resistant to enzymatic degradation.
• Branched peptides: Side chains of amino acids are grafted onto the main chain, creating a complex architecture.

The word "peptide" covers molecules that share nothing but their chemical structure. Semaglutide and BPC-157 are both peptides. The first has been tested in thousands of patients and is sold in pharmacies on prescription. The second remains a research compound, studied mainly in animals. Comparing them means comparing an approved medicine with a laboratory hypothesis.

The table below ranks the five families you will meet most often by their level of evidence in humans.

Incretins have the strongest record. In the STEP 1 trial (1,961 adults with overweight or obesity), once-weekly semaglutide reduced mean body weight by 14.9% over 68 weeks, compared with 2.4% on placebo. In the SURMOUNT-1 trial (2,539 participants), tirzepatide reached up to 20.9% over 72 weeks depending on the dose, compared with 3.1% on placebo.

Repair peptides rest on a different kind of data. BPC-157 accelerated healing of the transected Achilles tendon in rats, but no phase III trial in humans has been published. TB-500 is described as a synthetic form or fragment of thymosin beta-4, a protein involved in cell migration. Clinical trials have tested full-length thymosin beta-4, not the product sold for research. Finally, GHK-Cu modulates the expression of many genes linked to skin remodeling in laboratory studies.

So the right question is never "do peptides work?". It is always: which peptide, for which indication, with what type of study and in which population.

The distinction between peptides and proteins is often a source of confusion. In reality, both are made from the same building blocks — amino acids — but they differ in their size, structural complexity, and biological properties.

The 50-amino-acid rule: By biochemical convention, we refer to peptides for chains of 2 to approximately 50 amino acids, and proteins beyond that. This boundary is not absolute — insulin, with its 51 amino acids, is sometimes called a peptide, sometimes a protein. But this convention remains widely used in the scientific literature.

Structural differences:

• Peptides: Often have a flexible structure, sometimes with no defined three-dimensional conformation in solution. Some adopt stable conformations only when interacting with their target receptors.
• Proteins: Have a complex and defined three-dimensional structure (tertiary, quaternary), maintained by hydrogen bonds, hydrophobic interactions, disulfide bridges, and Van der Waals forces. This 3D structure is essential to their function.

Functional differences:

• Peptides: Often act as messengers or signals (peptide hormones, neurotransmitters). Their small size allows them to diffuse rapidly and interact with membrane receptors.
• Proteins: Fulfill structural functions (collagen, keratin), enzymatic functions (trypsin, DNA polymerase), transport functions (hemoglobin), and immune functions (antibodies).

Pharmacological differences: In therapeutics, peptides offer specific advantages: high specificity for their targets, low toxicity (natural metabolites), and fewer drug interactions. However, they are often less stable than proteins and more sensitive to enzymatic degradation, which poses challenges for their administration.

Your body is a veritable peptide factory. Hundreds of different peptides are produced continuously to regulate essential biological functions. Here are the main ones:

Insulin and glucagon: These two hormonal peptides produced by the pancreas regulate blood sugar levels. Insulin (51 AA) lowers blood sugar by facilitating glucose entry into cells. Glucagon (29 AA) does the opposite: it stimulates glucose release from the liver. Their balance is vital — a dysfunction leads to diabetes.

Oxytocin: Nicknamed the “love hormone,” this nonapeptide (9 AA) is secreted by the hypothalamus. It plays a central role in childbirth (uterine contractions), breastfeeding (milk ejection), and social bonding (attachment, trust, empathy).

Endorphins: These neuropeptides are the body's natural painkillers. Produced in response to pain, stress, or physical exercise, they bind to opioid receptors in the brain to reduce the sensation of pain and induce a feeling of well-being — the famous “runner's high.“

Glutathione: This tripeptide (glutamate-cysteine-glycine) is the main intracellular antioxidant. Present in virtually all cells, it protects against oxidative stress, participates in liver detoxification, and supports the immune system. Its levels decline with age, contributing to cellular aging.

Defensins and cathelicidins: These antimicrobial peptides form the first line of innate defense against infections. Secreted by epithelial cells and neutrophils, they perforate the membranes of bacteria, fungi, and enveloped viruses. Their role is so fundamental that deficiencies in antimicrobial peptides are associated with increased susceptibility to infections.

GHK-Cu: This copper tripeptide, naturally present in blood plasma, stimulates collagen production, accelerates wound healing, and possesses anti-inflammatory properties. Its plasma concentration decreases significantly with age, dropping from 200 ng/mL at age 20 to 80 ng/mL at age 60.

Therapeutic peptides represent one of the most dynamic segments of the pharmaceutical industry. In 2026, over 80 peptide drugs are approved worldwide, and more than 150 are in clinical trials. The global therapeutic peptide market exceeds $50 billion.

Why are peptides of such interest to medicine?

• High specificity: Peptides bind to their receptors with remarkable precision, reducing off-target effects.
• Good tolerability: Metabolized into natural amino acids, they produce few toxic metabolites.
• Diversity of action: A single peptide can modulate multiple biological pathways simultaneously.

Examples of major peptide drugs:

• Insulin: The first therapeutic peptide (1922), still one of the most widely used worldwide for the treatment of diabetes.
• Semaglutide (Ozempic/Wegovy): A GLP-1 analogue, this peptide has revolutionized the treatment of type 2 diabetes and obesity. It has become one of the most prescribed medications worldwide in 2025-2026.
• Cyclosporine: A cyclic peptide immunosuppressant used after organ transplants and in certain autoimmune diseases.
• Desmopressin: A synthetic analogue of vasopressin, used for diabetes insipidus and nocturnal enuresis.

Promising research peptides: Beyond approved drugs, several peptides are at the preclinical or early clinical research stage. BPC-157 is being studied for tissue repair, TB-500 (a fragment of Thymosin Beta-4) for wound healing and joint mobility, and KPV (a tripeptide derived from alpha-MSH) for its anti-inflammatory properties. These peptides are not yet approved as drugs and remain in the research domain.

The cosmetics industry has massively adopted peptides over the past two decades. Today, peptide serums and creams are among the most popular and scientifically well-documented anti-aging products.

The four categories of cosmetic peptides:

• Signal peptides: They send a message to skin cells to stimulate the production of collagen, elastin, and other components of the extracellular matrix. Matrixyl (palmitoyl pentapeptide-4) and Matrixyl 3000 are the best known. Clinical studies have shown a 36% reduction in wrinkles after 2 months of use.
• Neurotransmitter-inhibiting peptides: They block the release of acetylcholine at the neuromuscular junction, reducing the micro-contractions that form expression lines. Argireline (acetyl hexapeptide-8) is nicknamed “topical Botox” for this reason.
• Carrier peptides: They deliver essential trace elements to skin cells. GHK-Cu transports copper, an enzymatic cofactor crucial for collagen synthesis and antioxidant activity.
• Enzyme-inhibiting peptides: They block enzymes that degrade collagen and elastin (matrix metalloproteinases, or MMPs). By inhibiting these enzymes, they preserve the existing collagen reserves.

Proven efficacy: Unlike many cosmetic ingredients, several peptides have solid clinical data. Double-blind, placebo-controlled trials have demonstrated the efficacy of Matrixyl 3000 in reducing wrinkles, and that of GHK-Cu in improving skin thickness and firmness. These results place peptides among the best-validated anti-aging actives, alongside retinol and vitamin C.

Limitations: The main limitation of cosmetic peptides is skin penetration. Peptides are hydrophilic molecules that have difficulty crossing the lipid barrier of the epidermis. To overcome this problem, the industry uses chemical modifications (palmitoylation, acetylation) and advanced delivery systems (liposomes, nanoparticles).

To judge a claim about a peptide, you need to know which stage of research it comes from. Each stage answers a different question.

• In vitro (cultured cells): does the molecule bind to its target and trigger a measurable response? Most of the striking percentages quoted in marketing come from this stage, for example an increase in collagen production in fibroblasts. But cells in a dish have no liver, no kidneys and no immune system.
• Preclinical (animals, usually rodents): how is the molecule absorbed, distributed, broken down and eliminated, and is it toxic? Most of the data on repair peptides comes from this stage. Injury models are simplified and laboratory animals are genetically very uniform.
• Phase I: a small group of healthy volunteers. Researchers measure tolerability and what happens to the molecule in the body.
• Phase II: patients with the target disease. Researchers look for the first signs of efficacy.
• Phase III: large randomized placebo-controlled trials. They form the basis of a marketing authorization application to the EMA or the FDA.
• Phase IV: post-marketing surveillance, which detects rare adverse effects.

"No phase III trial" does not mean "ineffective". It means we do not know whether the substance is effective and safe in humans, because the study that would tell us has not been done or not completed. This distinction changes how you read almost everything that circulates about research peptides.

Peptides sold "for research" are not manufactured under the Good Manufacturing Practice (GMP) standards that apply to medicines. No authority checks their identity, purity or sterility before sale. The FDA has sent warning letters to companies selling this type of product.

The key document is the batch certificate of analysis (COA). A useful COA states:

• a batch number and an analysis date;
• purity measured by HPLC (high-performance liquid chromatography);
• a mass spectrometry analysis confirming that the mass matches the stated sequence;
• the name of the laboratory that performed the analysis, ideally one independent of the seller.

A certificate with no batch number and no laboratory name proves nothing. The most common impurities are incomplete sequences formed during synthesis, residual solvents and bacterial endotoxins.

The risks go beyond product quality. For most research peptides, there are no long-term safety data in humans. Interactions with current treatments and effects during pregnancy or breastfeeding are unknown. Some peptides act on blood vessel formation or cell proliferation, which calls for particular caution in people with a history of cancer. Finally, the World Anti-Doping Agency bans BPC-157 and growth hormone secretagogues in competition. To learn more, see our article are peptides safe?

Peptide research is accelerating at an unprecedented pace. Several major trends are shaping the future of this field:

Artificial intelligence and peptide design: AI is revolutionizing the discovery of new peptides. Deep learning algorithms can now predict the structure, stability, and biological activity of peptides that do not yet exist in nature. This approach, known as de novo peptide design, is considerably accelerating the development process for new therapeutic candidates.

Cyclic peptides and stapled peptides: To overcome stability and bioavailability limitations, researchers are developing modified peptides — cyclic, stapled, or incorporating non-natural amino acids. These modifications improve resistance to enzymatic degradation and facilitate passage through biological barriers, including the intestinal barrier for oral administration.

Peptide blends: The strategic combination of several peptides with complementary mechanisms is an emerging trend. Blends such as KLOW (BPC-157 + TB-500 + GHK-Cu + KPV) or GLOW (BPC-157 + TB-500 + GHK-Cu) leverage synergy between peptides to maximize potential therapeutic effects.

Peptides and personalized medicine: In the long term, the combination of genomics and peptide research could enable the design of personalized peptide treatments tailored to the genetic and biological profile of each individual.

Peptides are no longer mere biochemical curiosities. They have become first-line therapeutic tools and essential cosmetic ingredients. With current technological advances, their potential is only beginning to be explored.